2026-04-14T03:29:40Zhttps://recercat.cat/oai/request

oai:recercat.cat:10230/275642025-12-26T11:23:44Zcom_2072_6col_2072_452952

00925njm 22002777a 4500 dc Comas Serrano, Mercè author Mendivil, Joan author Andreu García, Montserrat author Hernández Rodríguez, Cristina author Castells, Xavier author 2016-11-22T12:35:19Z 2016-11-22T12:35:19Z 2016 OBJECTIVE: To estimate the long-term need for colonoscopies after a positive fecal immunochemical test (FIT) and post-polypectomy surveillance in the context of a population-based colorectal cancer (CRC) screening program. METHODS: A discrete-event simulation model was built to reproduce the process of CRC screening and post-polypectomy surveillance following European guidelines in a population of 100,000 men and women aged 50-69 years over a 20-year period. Screening consisted of biennial FIT and colonoscopy in participants with positive results. The model was mainly fed using data from the first and second rounds of a Spanish program (2010-2013). Data on post-polypectomy surveillance results were obtained from the literature. A probabilistic multivariate sensitivity analysis was performed on the effect of participation, FIT positivity, and adherence to surveillance colonoscopies. The main outcome variables were the number of colonoscopies after a positive FIT, surveillance colonoscopies, and the overall number of colonoscopies. RESULTS: An average yearly number of 1,200 colonoscopies after a positive FIT were predicted per 100,000 inhabitants with a slight increase to 1,400 at the end of the 20-year period. Surveillance colonoscopies increased to an average of 1,000 per 100,000 inhabitants in the long-term, showing certain stabilization in the last years of the 20-year simulation horizon. The results were highly sensitive to FIT positivity. ONCLUSIONS: Implementing a population-based CRC screening program will increase the demand for colonoscopies, which is expected to double in 20 years, mainly due to an increase in surveillance colonoscopies. Financial support for this study was provided to MC by grant number PI07/90357 from Instituto de Salud Carlos III-FEDER (www.isciii.es/) and number AP94422011 from Fundación Mutua Madrileña (www.fundacionmutua.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roche Diagnostics International Ltd., a commercial company, provided support in the form of salaries for JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ‘author contributions’ section. Còlon -- Càncer Colonoscòpia Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.